好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Technology as Treatment: Use of Virtual Complementary and Integrative Therapies by Patients in Neurology
General Neurology
P1 - Poster Session 1 (9:00 AM-5:00 PM)
169
Given the reductions in in-person visits and the increases in teleneurology visits, we sought to determine whether patients increased their use of virtual complementary and integrative therapies.  

Patients with neurological disorders may seek treatment options in addition to those recommended by their providers. Prior to the COVID-19 pandemic, about half of patients from populations that sought care in neurology tried complementary and integrative therapies (CITs).

By examining two separate datasets that included cohorts of patients with neurological disorders, we assessed patients’ use of virtual (and non-virtual) CITs and determined whether there were clinical characteristics that predicted their use. The two studies that comprised this report included one that examined patient and provider experiences with teleneurology visits, and another that assessed patients with a history of COVID-19 infection who presented for neurologic evaluation. 
Patients who postponed medical treatment for non-COVID-19-related problems during the pandemic were more likely to seek CITs. Virtual exercise, virtual psychotherapy and relaxation/meditation smartphone applications were the most frequent types of virtual CITs chosen by patients.  In both studies, age was a key demographic factor associated with mobile/virtual CIT usage. 
Data from our investigations demonstrated that, in addition to its other roles in teleneurology, CIT-related technologies may be utilized in the treatment of neurologic conditions.
Authors/Disclosures
Mia T. Minen, MD, FAAN (NYULMC Neurology)
PRESENTER 		The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Neil A. Busis, MD, FAAN (NYU Langone Health) Dr. Busis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生. Dr. Busis has received personal compensation in the range of $0-$499 for serving as a Consultant for American Medical Association. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Clinical Practice.
Steven Friedman Steven Friedman has nothing to disclose.
No disclosure on file
Ananya Sahu, Other Ms. Sahu has nothing to disclose.
Kazi S. Maisha Ms. Maisha has nothing to disclose.
Quazi I. Hossain Mr. Hossain has nothing to disclose.
Mia Soviero Miss Soviero has nothing to disclose.
No disclosure on file
Leslie Yao Ms. Yao has nothing to disclose.
Farng-Yang Foo, MD (NYU Faculty Practice) Dr. Foo has nothing to disclose.
Jaydeep M. Bhatt, MD (NYU Neurology) Dr. Bhatt has nothing to disclose.
Laura J. Balcer, MD, MSCE, FAAN (NYU Grossman School of Medicine) An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Steven Galetta, MD, FAAN (NYU Langone Medical Center) Dr. Galetta has nothing to disclose.
Sujata P. Thawani, MD (NYU Neurology Associates) Dr. Thawani has nothing to disclose.